Evidence map›Paper›PMID 36372279›Full record

ArticleJournal of molecular and cellular cardiology2023

HuR-dependent expression of Wisp1 is necessary for TGFβ-induced cardiac myofibroblast activity.

Lisa C Green, Samuel Slone, Sarah R Anthony, Adrienne R Guarnieri, Sharon Parkins, Shannon M Shearer, Michelle L Nieman, Sudeshna Roy, Jeffrey Aube, Xiaoqing Wu and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. HuR inhibition reduces post-ischemic cardiac remodeling by dampening myocyte-dependent inflammatory gene expression and the innate immune response.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  7. Article
  8. Research (Washington, D.C.) · 2025
    Article
  9. Article
  10. An overview of CCN4 (WISP1) role in human diseases.Journal of translational medicine · 2024
    Review
  11. Article
  12. Article
  13. Review
  14. RNA binding proteins as mediators of pathological cardiac remodeling.Frontiers in cell and developmental biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Lisa C GreenDepartment of Internal Medicine, Division of Cardiovascular Health and Disease, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America; Department of Pharmacology & Systems Physiology, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America.
Samuel SloneDepartment of Internal Medicine, Division of Cardiovascular Health and Disease, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America; Department of Pharmacology & Systems Physiology, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America.
Sarah R AnthonyDepartment of Internal Medicine, Division of Cardiovascular Health and Disease, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America.
Adrienne R GuarnieriDepartment of Internal Medicine, Division of Cardiovascular Health and Disease, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America.
Sharon ParkinsDepartment of Internal Medicine, Division of Cardiovascular Health and Disease, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America.
Shannon M ShearerDepartment of Internal Medicine, Division of Cardiovascular Health and Disease, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America; Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America.
Michelle L NiemanDepartment of Pharmacology & Systems Physiology, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America.
Sudeshna RoyDivision of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, United States of America.
Jeffrey AubeDivision of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, United States of America.
Xiaoqing WuDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, United States of America.
Liang XuDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, United States of America.
Onur KanisicakDepartment of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America.
Michael TranterDepartment of Internal Medicine, Division of Cardiovascular Health and Disease, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America. Electronic address: Michael.Tranter@UC.edu.
University of Cincinnati Medical Center · USUniversity of Kansas · USUniversity of North Carolina at Chapel Hill · US

Funding

Understanding Cardiovascular Disease MechanismsT32HL125204 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI Evangelia G Kranias, Jeffery D Molkentin · 2015 to 2026
$3.4M
Post-transcriptional control of adipose tissue gene expression as an endocrine mediator of cardiac pathologyR01HL158671 · NHLBI · UNIVERSITY OF CINCINNATI · PI Michael Tranter · 2022 to 2026
$3.1M
Nano-Engineered Lab-on-a-Chip for Assessing HuR-Regulated Exosomes for Cancer Monitoring and Targeted TherapyR01CA243445 · NCI · UNIVERSITY OF KANSAS LAWRENCE · PI DIXON, DAN ALAN, XU, LIANG · 2019 to 2023
$3.0M
Functional and mechanistic delineation of HuR-Wisp1 signaling on myofibroblast activityR01HL166326 · NHLBI · UNIVERSITY OF CINCINNATI · PI Onur Kanisicak, Michael Tranter · 2023 to 2026
$2.6M
Molecular cancer therapy targeting HuR-ARE interactionR01CA191785 · NCI · UNIVERSITY OF KANSAS LAWRENCE · PI AUBE, JEFFREY, XU, LIANG · 2015 to 2019
$2.1M
Regulators of extracellular matrix production during cardiac development and diseaseR01HL148598 · NHLBI · UNIVERSITY OF CINCINNATI · PI KANISICAK, ONUR · 2020 to 2024
$2.0M
Investigation of Human Antigen R (HuR) as a Novel Mediator of Cardiac HypertrophyR01HL132111 · NHLBI · UNIVERSITY OF CINCINNATI · PI TRANTER, MICHAEL · 2016 to 2020
$1.8M
Integrative Functional Profiling of Tumor-Derived Extracellular VesiclesR33CA252158 · NCI · UNIVERSITY OF FLORIDA · PI XU, LIANG, ZENG, YONG · 2021 to 2024
$1.0M
American Heart Association-American Stroke Association 16SDG27360004NCI NIH HHS R01 CA191785NCI NIH HHS R01 CA243445NCI NIH HHS R33 CA252158NHLBI NIH HHS R01 HL132111NHLBI NIH HHS R01 HL148598NHLBI NIH HHS R01 HL158671NHLBI NIH HHS R01 HL166326NHLBI NIH HHS T32 HL125204
6 · The paper itself

Abstract

Cardiac fibrosis is regulated by the activation and phenotypic switching of quiescent cardiac fibroblasts to active myofibroblasts, which have extracellular matrix (ECM) remodeling and contractile functions which play a central role in cardiac remodeling in response to injury. Here, we show that expression and activity of the RNA binding protein HuR is increased in cardiac fibroblasts upon transformation to an active myofibroblast. Pharmacological inhibition of HuR significantly blunts the TGFβ-dependent increase in ECM remodeling genes, total collagen secretion, in vitro scratch closure, and collagen gel contraction in isolated primary cardiac fibroblasts, suggesting a suppression of TGFβ-induced myofibroblast activation upon HuR inhibition. We identified twenty-four mRNA transcripts that were enriched for HuR binding following TGFβ treatment via photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP). Eleven of these HuR-bound mRNAs also showed significant co-expression correlation with HuR, αSMA, and periostin in primary fibroblasts isolated from the ischemic-zone of infarcted mouse hearts. Of these, WNT1-inducible signaling pathway protein-1 (Wisp1; Ccn4), was the most significantly associated with HuR expression in fibroblasts. Accordingly, we found Wisp1 expression to be increased in cardiac fibroblasts isolated from the ischemic-zone of mouse hearts following ischemia/reperfusion, and confirmed Wisp1 expression to be HuR-dependent in isolated fibroblasts. Finally, addition of exogenous recombinant Wisp1 partially rescued myofibroblast-induced collagen gel contraction following HuR inhibition, demonstrating that HuR-dependent Wisp1 expression plays a functional role in HuR-dependent MF activity downstream of TGFβ. In conclusion, HuR activity is necessary for the functional activation of primary cardiac fibroblasts in response to TGFβ, in part through post-transcriptional regulation of Wisp1.

Indexed as

CCN Intercellular Signaling ProteinsELAV-Like Protein 1MyofibroblastsTransforming Growth Factor betaAnimalsCollagenFibroblastsHeartMiceProto-Oncogene ProteinsCCN4 protein, mouseCCN Intercellular Signaling ProteinsCollagenElavl1 protein, mouseELAV-Like Protein 1Proto-Oncogene ProteinsTransforming Growth Factor betaFibroblastHuman Antigen R (HuR)MyofibroblastWNT1-inducible signaling pathway protein-1 (Wisp1)

Identifiers

PMID36372279
PMCPMC9868076
OpenAlexW4309511329

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.